- Report
- March 2024
- 183 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- December 2023
- 150 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- January 2024
- 150 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- April 2024
- 179 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- July 2023
- 179 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- April 2024
- 183 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Clinical Trials
- April 2024
- 65 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- March 2024
- 195 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- March 2024
- 199 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- March 2024
- 184 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2023
- 149 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- November 2023
- 140 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- June 2023
- 143 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- February 2024
- 110 Pages
Global
From €4592EUR$4,750USD£3,945GBP
The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids.
The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more